Showing 17–32 of 147 results
-
CABENUVA (cabotegravir extended-release injectable suspension). Get Access In India
Read more -
CALQUENCE (acalabrutinib) capsules, for oral use. Initial U.S. Approval: 2017
Read more -
Columvi (glofitamab) for injection
Read more -
COPIKTRA (duvelisib), capsules for oral use. Initial U.S. Approval: 2018
Read more -
COTELLIC (cobimetinib) tablets. FDA-Approved
Read more -
CYRAMZA (ramucirumab) injection, for intravenous use. Initial U.S. Approval: 2014
Read more -
DARAPRIM (pyrimethamine) 25-mg Scored Tablets
Read more -
DARZALEX (daratumumab) injection, for intravenous use. Initial U.S. Approval – 2015
Read more -
DAURISMO (glasdegib) tablets
Read more -
DUPIXENT (dupilumab) injection, for subcutaneous use. Initial U.S. Approval: 2017
Read more -
ELAHERE (mirvetuximab soravtansine-gynx) injection
Read more -
ELREXFIO (elranatamab-bcmm) injection
Read more -
ELZONRIS (tagraxofusp-erzs) injection, for intravenous use. Initial U.S. Approval: 2018
Read more -
EMPLICITI (elotuzumab) for injection
Read more -
ENTADFI (finasteride and tadalafil) capsules
Read more -
ERLEADA (apalutamide) tablets, for oral use. Initial U.S. Approval – 2018
Read more